EE430 Cost-Effectiveness of Tremelimumab or Tremelimumab in Combination with Durvalumab Vs Durvalumab As Treatment of Advanced Hepatocellular Carcinoma
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.731
https://www.valueinhealthjournal.com/article/S1098-3015(23)00831-8/fulltext
Title :
EE430 Cost-Effectiveness of Tremelimumab or Tremelimumab in Combination with Durvalumab Vs Durvalumab As Treatment of Advanced Hepatocellular Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00831-8&doi=10.1016/j.jval.2023.03.731
First page :
Section Title :
Open access? :
No
Section Order :
10205